UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribu

UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

The UAE pharmaceutical market is projected to grow at a formidable rate during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure in the country and high investments by market players in developing effective drugs and medicines. Besides, rising incidences of chronic disorders such as diabetes, cardiovascular diseases, renal disorders, and infectious diseases are expected to propel the growth of the UAE pharmaceutical market in the coming years.

The government of the United Arab Emirates is actively working to advance the pharmaceutical sector. Due to its potential for future growth, export potential, and medium- to long-term economic effect, the pharmaceutical industry is a target of initiatives such as the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030. The country's pharmaceutical needs were largely satisfied by imported medications and pharmaceutical goods. Through increased investments in the research and development of pharmaceutical and therapeutic products, the nation is actively working to reduce the import of pharmaceuticals and manufacture related products in the future.

The government is establishing relationships with major international market participants to enhance its production of pharmaceutical items. With favorable funding, distribution channel plans, strategic planning, and a highly developed logistics infrastructure, the UAE pharmaceutical business is expected to grow over the next five years.

The country's pharmaceutical industry is expanding due to the rising incidence of chronic diseases, infectious diseases, and lifestyle disorders. Chronic conditions like cancer, neurological illnesses, and cardiovascular diseases are propelling the market's expansion. Both male and female residents of the nation were found to have 4,807 new instances of cancer.

The increased demand for pharmaceutical products was helped by infectious disorders brought on by increased tourism, environmental factors, and the most recent viral infection brought on by COVID-19. The government also supported the idea by increasing investment in the sector. Disrupted import routes have forced pharmaceutical companies to manufacture pharmaceuticals in the country.

The UAE pharmaceutical market is segmented based on drug type, product type, application, distribution channel, competitional landscape, and regional distribution. Based on drug type, the market is divided into generic drugs and branded drugs. The branded drugs are anticipated to register the highest growth during the forecast period, owing to the rising personal disposable income among the population and rising penetration of global giants with patent products.

Major players operating in the UAE pharmaceutical market are Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F–2027F

Objective of the Study:

• To analyze the historical growth in the market size of the UAE pharmaceutical market from 2017 to 2021.
• To estimate and forecast the market size of UAE pharmaceutical market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast the UAE pharmaceutical market based on drug type, product type, application, distribution channel, region, and company.
• To identify the dominant region or segment in the UAE pharmaceutical market.
• To identify drivers and challenges for the UAE pharmaceutical market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the UAE pharmaceutical market.
• To identify and analyze the profiles of leading players operating in the UAE pharmaceutical market.
• To identify key sustainable strategies adopted by market players in UAE pharmaceutical market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of the UAE pharmaceutical market using a bottom up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• UAE Pharmaceutical Market, By Drug Type:
• Generic Drugs
• Branded Drugs
• UAE Pharmaceutical Market, By Product Type:
• Prescription Drugs
• Over-The-Counter Drugs
• UAE Pharmaceutical Market, By Application:
• Cardiovascular
• Musculoskeletal
• Oncology
• Anti-infective
• Metabolic Disorder
• Others
• UAE Pharmaceutical Market, By Distribution Channel:
• Retail Pharmacy
• Hospital Pharmacy
• E-Pharmacy
• UAE Pharmaceutical Market, By Region:
• Dubai Region
• Sharjah Region
• Abu Dhabi Region
• Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights